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Abstract
 .  .To further elucidate the nature of the molecular interactions of surfactant apoprotein B SP-B with phospholipid PL
membranes, we studied the binding of SP-B to PL membranes and the lipid-dependency of its subsequent effects on leakage
and fusion of membranes. SP-B binding to membranes was studied by labeling the protein with the fluorophore
 .7-nitro-2,1,3-benzoxadiazol-4-yl NBD and measuring the fluorescence of the labeled protein in the presence of varying
 .amounts of dipalmitoylphosphatidylcholine–egg phosphatidylglycerol DPPC–eggPG; 7–3 . Leakage of contents from
 .liposomes made of DPPC and varying molar fraction of egg phosphatidylcholine eggPC or eggPG was assessed by
measuring the fluorescence of entrapped water-soluble probes ANTS and DPX. Fusion of membranes was assessed by
 . measuring the fluorescence of membrane-bound NBD–phosphatidylethanolamine NBD–PE and rhodamine–PE RHO–
.PE . We found that SP-B bound to PL membranes with high affinity and appeared to irreversibly cluster at the membrane
surface, leading to graded release of the vesicle contents and eventually fusion of the membranes with increasing
protein–lipid ratios. All lipid mixtures tested were susceptible to the membrane disruptive effects of SP-B, but DPPC–eggPG
membranes displayed a biphasic response to increasing molar fractions of eggPG, whereas increasing fractions of eggPC
elicited a monotonic response. q 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Recently, a mutation of the surfactant apoprotein B
 .SP-B gene leading to congenital SP-B deficiency
was reported in several neonates who died of refrac-
w xtory respiratory distress 1 . Microscopic examination
of the lungs of these infants showed misshapen
) Corresponding author. Fax: q1-415-476-3586; E-mail:
poulain@itsa.ucsf.edu
lamellar bodies and aberrant processing of another
surfactant apoprotein, SP-C. A model of SP-B defi-
w xciency engineered in the mouse 2 has since repro-
duced both the clinical course and the pathological
findings observed in the human, confirming the ap-
parent importance of SP-B to normal lung function.
SP-B is one of four known surfactant apoproteins.
The protein monomer is a 79 amino-acid long peptide
predicted by primary and secondary structure analysis
to form at least four amphipathic helices approxi-
mated in a hairpin-like tertiary configuration through
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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w xdisulfide bonding 3 . SP-B is found in its secreted
form as a 18-kDa dimer, and it is processed from a
w xlarger, 42-kDa preprotein in type II cells 4,5 . SP-B
processing, its secondary structure and pattern of
disulfide bonding are similar to those of other mem-
w xbers of the saposin-like family of proteins 6 . This
newly described protein family includes, amongst
w x w xothers, the four saposins 7 , porcine NK-lysin 3 , the
w xamoebapores of Entamoeba histolytica 8 and hu-
w xman granulysin 9 . The biological role varies amongst
members of this protein family, but they all interact
with lipids.
We previously reported that SP-B induces exten-
sive fusion of liposome membranes and complete,
w xrapid leakage of liposome contents 10 . In a later
report, we further characterized the interaction of
SP-B with lipids using a mass action kinetic model of
membrane fusion and showed a dose-dependent ef-
fect of SP-B on aggregation and fusion rate constants,
an effect that was further increased by calcium and
w xSP-A 11 . We now report experiments investigating
 .the binding of SP-B to phospholipid PL membranes
and the dependency of the subsequent membrane
fusion and leakage of contents on the target PL
composition. Our results suggest that SP-B binds to
lipids with high affinity and irreversibly aggregates in
the membrane, leading first to destabilization of the
membrane and a graded release of the liposome
contents, and second to fusion between disrupted
membranes. Some degree of leakage of liposome
contents and fusion of membranes was observed with
all lipid mixtures tested, but differences in the protein
dose–response curves were observed depending on
the charge of the PL headgroups. These results help
further our understanding of the role of SP-B in the
normal and diseased lung by providing a detailed
account of molecular events that may be of impor-
tance in lamellar body formation and the structural
rearrangements that take place amongst the lipopro-
teins of secreted surfactant.
2. Materials and methods
2.1. Materials
 .Dipalmitoylphosphatidylcholine DPPC , dipalmi-
 .toylphosphatidylglycerol DPPG , egg phosphatidyl-
 .choline eggPC and egg phosphatidylglycerol
 .eggPG were purchased from Avanti Polar Lipids
 .Birmingham, AL . PL purity was checked by thin
w xlayer chromatography 12 . Fluorescent lipid probes,
 .N- 7-nitro-2,1,3-benzoxadiazol-4-yl –phosphatidy-
 . lethanolamine NBD–PE , and N- lissamine rho-
.  .damine B sulfonyl –PE RH–PE were from Avanti
Polar Lipids. Fluorescent aqueous probes, 1-amino-
 . X naphtalene-3,6,8,-trisulfonic acid ANTS , N, N - p-
.  .phenylenedimethylene bis pyridinium bromide
 .DPX , and 4-fluoro-7-nitrobenz-2-oxa-1,3-diazole-
 .4yl fluoro-NBD were from Molecular Probes
 .  .Eugene, OR . 2-Amino-2- hydroxymethyl -1,3-
 .  .propanediol Tris , fluorescamine, 3 N-Morpholino -
 .2-hydroxy-propanesulfonic acid MOPSO , dimethyl-
 .formamide DMF , ethylenediaminetetraacetic acid
 . EDTA and calcium chloride were from Sigma St.
.Louis, MO . Sephadex LH-60 and G-75 were from
 .Pharmacia Piscataway, NJ . C E , n-Octyl-b-D-12 8
 . glucopyranoside OGP were from Calbiochem San
.Diego, CA . Organic solvents of HPLC grade were
 .from Mallinckrodt Paros, KY .
2.2. Preparation of surfactant apoproteins
Surfactant proteins were isolated from dog and
human surfactant using previously described methods
w x13,14 . Surfactant was first extracted in 1-butanol
 .1:50; vol:vol at room temperature and then cen-
trifuged twice at 6000=g for 20 min to sedimentav
the butanol-insoluble proteins. The resulting pellet
was dried under N and washed twice in 5 mM2
Trisr150 mM NaClr20 mM OGP, pH 7.4. The
precipitate was then solubilized in 5 mM Tris buffer,
pH 7.4, and dialyzed for 48 h against four changes of
the same buffer. Remaining insoluble material was
removed by centrifugation at 100,000=g for 30av
min. The resulting supernatant containing SP-A was
w x assayed for protein content 15 and purity SDS-
.PAGE , then stored at y208C. Stock solutions of
 .SP-A 500 mgrml in 5 mM Tris, pH 7.4 were used
in all experiments. The hydrophobic protein SP-B
was purified from the butanol supernatant. The super-
natant was dried by rotary evaporation and resolubi-
lized in chloroformrmethanolr0.1 M HCl 1:1:0.1;
.vol:vol . Insoluble material was removed by centrifu-
gation and the supernatant was applied to a 3=85
cm Sephadex LH-60 column and eluted at 18 mlrh
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using the same solvent at room temperature. The
eluted fractions were assayed by SDS-PAGE without
reduction of the sample and SP-B containing frac-
tions pooled accordingly. The pooled fractions were
assayed for protein content by fluorescamine analysis
w xin the presence of 0.1% SDS 16 and stored at 48C.
For all experiments, SP-B was dried under N to2
 .remove the HCl, resolubilized 500 mgrml in
methanol, and added out of methanol to the vesicle
suspension in buffer. Molecular weights of 650,000
and 18,000 for SP-A and SP-B, respectively, were
used for the calculation of protein molarity.
2.3. SP-B labeling
 .Purified SP-B 0.3 mg was reacted with 0.8 mM
fluoro-NBD in 500 ml dry dimethylformamide for 24
w xh, at room temperature, in the dark 17 . Labeled
protein was then dried under nitrogen and resolubi-
lized in 200 ml of dichloromethanermethanolr0.1 N
 .HCl 60:35:5 , and separated from free label on a
LH-60 HPLC column in methanolrdichloro-
 . w xmethaner0.1 N HCl 65:30:5 solvent 18 . Labeling
efficiency was about 1.6 mol of NBD per mol of
SP-B. Labeled SP-B was resolubilized in methanol
before use. The lytic effects of labeled and unlabeled
protein on liposomes were indistinguishable, suggest-
ing that labeling did not interfere with the biological
 .properties of SP-B not shown .
2.4. Liposome preparation
PL mixtures were dried under N and resuspended2
in 50 mM MOPSOr140 mM NaClr0.1 mM EDTA
buffer, pH 6.9 at 378C. PL suspensions were then
passed through an ‘Extrudere’ Lipex Biomem-
.branes, Vancouver, BC, Canada under 50 to 500 psi
argon pressure. The liposomes used for all experi-
ments were obtained by a series of sequential extru-
sions through two stacked 0.2 mm, and 0.1 mm
polycarbonate filters, which produce vesicles of 100
w xnm median diameter 10 . PL concentration was mea-
w xsured by phosphorus assay 19 . Liposome stock sus-
 .pensions 2.0 M PLs were stored at 48C.
2.5. SP-B binding to lipidsraggregation in the mem-
branerre˝ersibility
NBD quantum yield and blue shift of the maximal
emission wavelength increase with the hydrophobic-
ity of the fluorophore environment, a property which
has been used to study the interaction of NBD-labeled
w xproteins with lipid bilayers 20 . To first determine
the wavelength of maximum fluorescence emission
of the labeled protein in the presence of lipids, fluo-
rescence excitation was set at 450 nm and emission
spectra were recorded at 378C, under constant stir-
ring, in the temperature-controlled 2 ml cuvette of a
Fluorolog 2 spectrofluorometer SPEX Industries,
.Edison, NJ , equipped with a light-proof port allow-
ing for injection of reagents without interruption of
 .the recording. Emission at this wavelength 530 nm
was then recorded before and after addition of 0.1 mg
NBD-labeled SP-B to increasing amounts of DPPC–
eggPG PLs. The maximum fluorescence observed
was used for calculation of binding estimates after
corrections were made for the intrinsic fluorescence
of lipids and of labeled SP-B in buffer alone. Cor-
rected fluorescence in the absence of lipids was taken
as a fraction bound of 0 and that in the presence of
2=105 molar excess of lipids as a fraction bound of
1.
At high SP-BrPL ratios fluorescence decayed af-
ter reaching its maximum. This self-quenching of the
fluorophore is consistent with surface aggregation of
w xSP-B in the PL membrane 21 . To quantify the
surface aggregation of SP-B in the membrane, we
used the absolute decrease in fluorescence over the 5
min following maximum as a numerical correlate of
surface aggregation. The values obtained at various
SP-BrPL ratios were then linearly transformed using
a scale of 0 to 100.
In separate experiments, we studied the reversibil-
ity of the surface aggregation of SP-B, using a fixed
20 mgrml PL concentration and different amounts of
 .labeled SP-B 0.01, 0.1 or 1.0 mg . Fluorescence
after addition of labeled SP-B was recorded for 10
min before unlabelled SP-B was injected in 20-fold
 .excess 0.2, 2.0 or 20 mg , and for the following 10
min.
2.6. Measurement of lipid mixing
Lipid mixing was measured by the method of
resonance energy transfer between the non exchange-
w xable fluorophores NBD–PE and Rhodamine–PE 22 .
In all experiments, the molar ratio of fluorophores to
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PLs in labeled liposomes was 0.01 and 1:9 mixtures
of labeled:unlabeled liposomes were used. Excitation
and emission were set at 450 and 520 nm, respec-
 .tively. Baseline fluorescence 0% was that before
any addition of reagents, and maximum fluorescence
 .100% that after addition of the non-ionic detergent
C E .12 8
2.7. Measurement of leakage of liposome contents
Leakage of liposome contents was measured using
the water-soluble fluorescent probe ANTS and its
w xcollisional quencher DPX 23 . Liposomes were pre-
pared in buffer containing 12.5 mM ANTS and 45
mM DPX and free probes were removed on a
 .Sephadex G-75 column 1.5 cm=20 cm . Excitation
was set at 360 nm and emission was recorded at 520
nm through a Corning 470 nm cut-off filter, while
other experimental conditions were identical to those
used for the measurement of lipid mixing. Baseline
fluorescence was that before any addition and maxi-
mum fluorescence that after C E detergent lysis.12 8
To determine whether leakage of contents occurred
as an ‘all or none’ i.e., some of the liposomes
.release all of their contents vs. a ‘graded’ release
 .i.e., all of liposomes release some of their contents ,
we performed the following experiments. Liposome
suspensions were prepared that contained decreasing
fraction amounts of the fluorophores used in the
 .leakage assay 12.5 mM ANTS and 45 mM DPX .
 .Fig. 1. Binding of SP-B to PLs. A 0.1 mg of NBD-labeled SP-B
was added at 60 s, out of methanol, to increasing amounts of
 .DPPC-eggPG 7–3;wt–wt in 50 mM MOPSOr140 mM
NaClr0.1 mM EDTA buffer, pH 6.9, 378C. Fluorescence was
recorded at 530 nm. Four representative tracings are shown,
corresponding to SP-BrPL molar ratios of 7=10y4, 1=10y4,
y5 y6  .2=10 and 5=10 . B Peak fluorescence after addition of
the labeled SP-B was corrected for fluorescence of the lipids
alone and of the labeled protein in buffer and plotted against the
SP-BrPL molar ratios. The calculated values derived from the
 .analytical model are also shown for comparison. C Unlabeled
 . SP-B 2 mg was added in 20-fold excess of labeled SP-B 0.1
.  .mg to varying amounts of DPPC-eggPG 7–3;wt–wt in 50 mM
MOPSOr140 mM NaClr0.1 mM EDTA buffer, pH 6.9, 378C.
Both proteins were added out of methanol, labeled SP-B at 60 s,
unlabeled SP-B at 360 s. Fluorescence was recorded at 530 nm.
Three representative tracings are shown, for SP-BrPL molar
ratios of 1=10y4, 2=10y4 and 1=10y3.
The fluorescence of each liposome suspension was
 .measured before baseline fluorescence and after
 .detergent lysis final fluorescence . Baseline to final
fluorescence ratios were plotted against the amount
of fluorophores present in the liposomes before lysis,
allowing a DPX quenching curve to be generated.
 .Then, separate DPPC–eggPG 7–3 liposome sus-
pensions containing 12.5 mM ANTS and 45 mM
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DPX were reacted with varying amounts of SP-B and
fluorophores released in each sample were removed
by G-75 Sephadex chromatography at the end of each
experiment. Following chromatography, sample fluo-
rescence was measured before and after detergent
lysis to generate sample baseline to final fluorescence
ratios. Baseline to final fluorescence ratios are pre-
dicted to remain constant in ‘all or none’ release or to
match values of the quenching curve in a ‘graded’
w xrelease 24 .
3. Results
3.1. SP-B binding to lipids
To characterize SP-B binding to lipids, NBD-
labeled SP-B was reacted with varying amounts of
 .DPPC–eggPG 7–3 . Upon interaction with lipids the
fluorescence emitted by the labeled protein under-
 .went a blue shift not shown . The magnitude of the
 .blue shift 10–12 nm was consistent with the label
 .Fig. 2. Leakage of liposome contents induced by SP-B. A 20 mgrml DPPC-eggPC liposomes containing the water-soluble fluorescent
probes ANTS and DPX were incubated in 50 mM MOPSOr140 mM NaClr0.1 mM EDTA buffer, pH 6.9, 378C. EggPCrPL molar
ratios were 0.0, 0.3 and 1.0, respectively. Varying amounts of SP-B were added to the suspension out of methanol at 1 min. The
 .fluorescence values reached 10 min after injection of SP-B were plotted against SP-BrPL molar ratios. B Liposomes eggPG molar
 .  .ratios were 0.0, 0.1, 0.3, 0.7 and 1.0, respectively. The remainder of the experimental procedure was as in A . C Fluorescence emitted
 .by 20 mgrml DPPC-eggPC liposomes of varying eggPC molar ratios 0.0; 0.3; 1.0 , 10 min after injection of human SP-B at a SP-BrPL
y3  .  .molar ratio of 5=10 . The remainder of the experimental procedure was as in A . D Fluorescence emitted by 20 mgrml
 .DPPC-eggPG liposomes of varying eggPG molar ratios 0.0; 0.3; 0.7; 1.0 , 10 min after injection of human SP-B at a SP-BrPL molar
y3  .ratio of 5=10 . The remainder of the experimental procedure was as in A .
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residing at the surface of the bilayer rather than
w xburied within 17 . The fraction of SP-B bound was
derived from the maximum fluorescence observed
after correction for intrinsic fluorescence of the lipids
 .and of the labeled protein Fig. 1B . Data were
w xanalyzed after a procedure outlined by Nir et al. 25 .
SP-B bound to DPPC–eggPG with an apparent sur-
face partition coefficient of 2.7=107 My1. An esti-
mated 600"300 sites per liposome were present for
SP-B binding. There was no evidence of positive or
negative cooperativity. Estimates of the number of
SP-B molecules bound per liposome at various SP-
BrPL molar ratios, shown in Fig. 4, indicate that
fewer than 50 bound molecules per liposome ap-
peared necessary to elicit significant leakage of lipo-
some contents. The apparent binding affinity of SP-B
for DPPC–eggPG increased linearly with the amount
 .of eggPG present in the membrane not shown .
Following injection of the labeled protein in the
cuvette containing the liposome suspension, fluores-
cence intensity reached a maximum and decayed with
 .time due to NBD self-quenching Fig. 1A and C .
Although most of the measurements were made using
concentrations of labeled SP-B of 0.1 mgrml, we
 . found that at lower 0.01 grml or higher 1.0
.mgrml concentrations of labeled SP-B, the fluores-
cence intensity decay exhibited similar dependency
 .on SP-Brlipid molar ratios data not shown . The
fluorescence intensity decay increased with SP-
Brlipid molar ratios, suggesting that SP-B molecules
aggregated in the membrane. No dequenching was
seen following addition of large excess unlabelled
 .SP-B Fig. 1C , indicating that the surface aggrega-
tion of SP-B molecules did not reverse rapidly. The
lack of reversal seemed independent of the absolute
 .amount of SP-B added not shown .
3.2. Leakage of liposome contents
To determine the influence of lipid composition on
leakage of liposome contents by SP-B, DPPC–eggPG
and DPPC–eggPC liposomes of increasing molar
 .fractions 0 to 1 of eggPG and eggPC were reacted
with varying amounts of SP-B. Irrespective of lipid
composition, leakage increased with the SP-BrPL
 .ratio Fig. 2A and B . However, whereas leakage
proportionately increased with the fraction of eggPC
 .present Fig. 2C , it displayed a biphasic pattern
 .when the unsaturated lipid was eggPG Fig. 2D . At
Table 1
Analysis of mechanism of leakage of liposome contents by SP-B
y3 .SP-BrPL =10 Baselinerfinal fluorescence ratios
Experimental Predicted
‘Graded’ ‘All or none’
0.25 0.26 0.28 0.21
0.50 0.27 0.30 0.21
1.25 0.33 0.35 0.21
2.50 0.46 0.43 0.21
3.75 0.56 0.52 0.21
See Section 2 for experimental conditions.
the SP-BrPL molar ratio displayed in Fig. 2D 5=
y3.10 , induced leakage was highest at 0.3 eggPG
mole fraction and decreased slightly with increasing
eggPG mole fractions. However, at lower SP-BrPL
 y4 .molar ratios 5=10 , leakage was maximum at an
eggPG mole fraction as small as 0.1. Substituting
DPPG for eggPG did not alter the extent of leakage
 .not shown .
We also determined whether liposome contents
were released in an ‘all or none’ or ‘graded’ fashion.
 .Only DPPC–eggPG 7–3 liposomes were used for
these experiments. The results shown in Table 1
indicate that the pattern of leakage was most consis-
tent with graded release of the liposome contents, as
the measured values followed the predicted values for
graded release closely, even at SP-BrPL molar ratios
 y3.3.75=10 that promoted over 80% release of the
liposome contents.
3.3. Liposome fusion
Several PL mixtures of various composition were
tested in a membrane fusion assay to determine the
influence of PL composition on the degree of mem-
brane fusion by SP-B. In all combinations tested, the
degree of lipid mixing increased with the SP-B molar
 .ratio Fig. 3A and B , as reported before for
w xeggPGrPL ratios of 0.3 11 . Also, similar to what
was seen with leakage of contents, the extent of
 .fusion increased monotonically with eggPC Fig. 3C ,
 .but not with eggPG molar ratios Fig. 3D . Fusion of
eggPG-containing liposomes was minimal with pure
eggPG and reached its maximum at eggPG molar
ratios of 0.1 to 0.3. Substituting DPPG for eggPG did
 .not alter the extent of fusion observed not shown .
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 .  .Fig. 3. Liposome membrane fusion induced by SP-B. A A mixture of labeled with NBD-PE and Rhodamine-PE and unlabeled
 .DPPC-eggPC liposomes 20 mgrml was incubated in 50 mM MOPSOr140 mM NaClr0.1 mM EDTA buffer, pH 6.9, 378C.
EggPCrPL molar ratios were 0.0, 0.3, 0.7 and 1.0, respectively. Varying amounts of SP-B were added to the suspension out of methanol
 .at 1 min. The fluorescence values reached 10 min after injection of SP-B were plotted against SP-BrPL molar ratios. B Liposomes
 .  .eggPG molar ratios were 0.0, 0.1, 0.3, 0.7 and 1.0, respectively. The remainder of the experimental procedure was as in A . C
 .Fluorescence emitted by 20 mgrml DPPC-eggPC liposomes of varying eggPC molar ratios 0.0; 0.3; 0.7; 1.0 , 10 min after injection of
y3  .  .human SP-B at a SP-BrPL molar ratio of 3=10 solid line , under experimental procedure as that in A . Similar experiments were
 .  .  .carried out in the presence of 5 mM calcium short dashed line and 5 mM calcium and 50 nM dog SP-A long dashed line . D
 .Fluorescence emitted by 20 mgrml DPPC-eggPG liposomes of varying eggPG molar ratios 0.0; 0.1; 0.3; 0.7; 1.0 , 10 min after injection
y3  .  .of human SP-B at a SP-BrPL molar ratio of 3=10 solid line , under experimental procedure as that in A . Similar experiments were
 .  .carried out in the presence of 5 mM calcium short dashed line and 5 mM calcium and 50 nM dog SP-A long dashed line .
Calcium andror SP-A had no effect on eggPC-con-
 .taining mixtures Fig. 3C but enhanced the fusion of
eggPG-containing liposomes, with maximum en-
hancement seen between molar ratios of 0.3 and 0.7
 .of eggPG Fig. 3D . In separate experiments using
cholesterol, we found that as much as 10% choles-
terol by weight did not measurably alter the final
extents of fusion observed with eggPG-containing
 .mixtures not shown .
Fig. 4 shows estimates of membrane binding and
surface aggregation of SP-B and measured final ex-
tents of leakage and fusion plotted against SP-BrPL
molar ratios. The figure also displays the estimated
number of SP-B molecules bound per liposome at
each SP-BrPL molar ratio tested in the binding assay
 .upper =-axis . Aggregation of SP-B was detectable
 y5.at SP-B molar ratios -3=10 that caused no
measurable leakage or fusion, and reached its maxi-
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Fig. 4. Protein binding and surface aggregation, leakage of
contents and fusion of liposomes by SP-B. Binding of SP-B
 .filled circles , surface aggregation of SP-B at the membrane
 .  .crosses , extent of leakage of contents circles and membrane
 .fusion triangles after 10 min were plotted against SP-BrPL
 .molar ratios for a DPPC-eggPG 7–3 liposome mixture. The
upper x-axis displays the estimated number of SP-B molecules
bound at various SP-BrPL molar ratios and corresponding mass
fractions of bound SP-B. Experimental procedures for binding,
leakage and fusion are outlined in the legends of Fig. 1B, Fig.
2A, and Fig. 3A, respectively. Surface aggregation of SP-B at the
membrane was expressed as the amount linearly transformed to
.a scale of 0 to 100 of NBD fluorescence quenching observed in
the 5 min following injection of labeled SP-B.
mum values after about 15–20 molecules of SP-B
were bound. Leakage was detectable at SP-B molar
ratios greater than 5=10y5, when surface aggrega-
tion of the protein had reached half its maximum, and
fusion at ratios greater than 5=10y4, when surface
aggregation was maximum and leakage half-maxi-
mum.
4. Discussion
The lipid composition of surfactant is complex and
the importance of its various components to its func-
tions is only partially understood. The recent charac-
w x w xterization of human 1 and mouse 2 SP-B defi-
ciency emphasizes the importance of SP-B biological
role, and strongly suggests that it is at least in part
mediated through an interaction with lipids, those in
lamellar bodies and in secreted surfactant.
The first goal of our study was to investigate in
detail the influence of lipid composition on the inter-
action of SP-B with lipid membranes using well-
characterized in vitro assays of liposome lysis and
w xmembrane fusion 10 . SP-B is an hydrophobic,
cationic dimer, and its affinity for negatively charged
w xPLs has been well documented 26,27 . We and
others have previously shown that SP-B is a potent
w xfusogen of eggPG-containing PL membranes 11,28 ,
a function which may be relevant to the formation of
w xtubular myelin and lamellar bodies 10,29 . As was
the case in our previously reported experiments
w x10,11 , SP-B was added to pre-formed liposomes
from a methanol solution. This method of addition
may have influenced our results by protein loss to
precipitation. We did not attempt to compare bulk
phase SP-B content with that of the final lipoprotein
products. Our present results indicate that maximum
lysis and fusion of DPPC–eggPG membranes were
obtained with eggPGrPL molar ratios of 0.1 or 0.3.
At eggPGrPL molar ratios equal to or greater than
0.5, the magnitude of the measured effects rapidly
decreased, even though the binding of SP-B to the
lipid membranes kept increasing.
The synergistic effects of SP-A and calcium on
SP-B-induced leakage and fusion were maximum at
an eggPGrPL molar ratio of 0.3, indicating that
certain PL stoichiometries might optimize lysis and
membrane fusion by SP-B. The molecular basis for
our observation remains unclear, but may be related
to levels of membrane destabilization, pattern of do-
main formation or other similar mechanisms. As
w xanalyzed in detail previously 30,31 , calcium pro-
motes fusion of liposomes that contain acidic PLs in
at least two ways: by promoting membrane aggrega-
tion and by rendering the membranes more fusogenic.
In a system of mixed PL liposomes, the effective
concentration of calcium at the surface of liposomes
will increase with the magnitude of the negative
charge density, i.e., the content of anionic lipids.
Consistent with this observation, we found that the
enhancing effect of calcium on SP-B-induced mem-
brane fusion increased with the eggPG content Fig.
.3D . As the eggPG mole fraction was increased from
0.1 to 1.0, the enhancing effect of calcium increased
 .  .by 10% =1.1 to 300% =3.0 over baseline. The
enhancement of fusion by calcium and SP-A in com-
bination followed a similar pattern of increasing ef-
fect with the eggPG mole fraction. However, the
extent of the fusion reaction ultimately depends on
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the rate limiting step in the reaction. As Fig. 3D
indicates, the maximal extent of fusion occurred at an
eggPG mole fraction of 0.3. At that fraction, the
membrane destabilizing effect of SP-B by itself or in
combination with calcium and SP-A was maximum.
Similar mole fractions of eggPG were found to pro-
mote optimal formation of tubular myelin in vitro by
w xSuzuki et al. 32 .
Unsaturated PC also promoted extensive leakage
and membrane fusion by SP-B, but the effects ob-
served were monotonically related to the amount of
eggPC present, unlike the effects of SP-B on eggPG.
Native surfactant contains about 25% unsaturated PC
w x33 , possibly more in certain species, and yet its role
in surfactant remains unclear. Although SP-B clearly
interacted with eggPC-containing membranes and in-
duced leakage and fusion to extents similar to those
observed with eggPG-containing membranes, calcium
and SP-A had no enhancing effect in the absence of
negatively charged PLs. This added property of
eggPG more likely relates to the charge of the head-
group than to differences in the phase transition
temperatures between the respective mixtures, as
DPPG and egg PG behaved similarly in our assays.
On the other hand, the role of unsaturated PC in
surfactant may be more complex than its broadening
w xeffects on the phase transition of PL mixtures 34 .
Cholesterol had no measurable impact on lysis or
fusion by SP-B on DPPC–eggPG membranes, even
when present at cholesterolrPL molar ratios of 0.2
 .10% by weight , in contrast to its effects on the
surface properties of mixtures of DPPC and SP-B
w xmeasured by the Wilhelmy plate method 35 .
The second goal of our study was to characterize
the binding of SP-B to eggPG-containing membranes
by labeling the protein with NBD, a fluorescent
molecule which increases its quantum yield in hy-
drophobic environments. Our results show that, within
the conditions of our experiments, SP-B bound to
DPPC–eggPG membranes with high affinity surface
7 y1.partition coefficients2.7=10 M . The exact
affinity of SP-B for lipids in vivo may be quite
different however, and cannot be safely extrapolated
from our results. SP-B appeared to aggregate in the
membrane at high protein-to-lipid molar ratios, as
indicated by the NBD self-quenching we noted. This
surface aggregation of SP-B was also suggested by
others using deuterium nuclear magnetic resonance in
w xthe study of PLrSP-B mixtures 36 . The phe-
nomenon of fluorescence quenching was not reversed
by the addition of non-labeled protein, suggesting
that protein aggregates dissociated slowly under these
conditions. Combined with our observation that SP-B
induced a ‘graded’ release of liposomes contents, the
irreversibility of the protein surface aggregation sug-
gests that the protein clusters were not pore-forming.
The actual membrane topography and size of the
putative SP-B protein clusters remain uncertain. Al-
though as many as 600 SP-B binding sites may exist
on the membrane of a liposome 100 nm in diameter,
our results suggest that surface aggregation of the
protein was already maximum after as few as 15
 .SP-B molecules had bound Fig. 4 . For a given
amount of PLs, fusion required about 10-fold more
SP-B than did leakage and 100-fold more than did
maximal surface aggregation of SP-B to occur. No
significant destabilization of the membrane was de-
tected until surface aggregation of the protein ap-
peared to be maximal. Our results point to a dose-re-
lated effect of SP-B on membrane integrity, from
irreversible protein aggregation at the surface of the
liposome membrane to graded release of liposome
contents and eventually fusion of the membranes.
However, the precise stoichiometries of protein and
lipids interacting at various bulk ratios remain uncer-
tain and may be altered by the structural rearrange-
ments of membranes occurring with each process
w x10 .
Our present studies show that SP-B binds to lipids
with high affinity. Following its aggregation at the
membrane surface, SP-B causes membrane destabi-
lization leading to membrane fusion. The destabiliz-
ing effects of SP-B on membranes showed a definite
dependency on lipid composition, with a biphasic
response to eggPG and a monotonic response to
eggPC content. These observations may be of rele-
vance to the role of SP-B in vivo and influence the
choice of composition and stoichiometry in new for-
mulations of exogenous surfactant preparations for
replacement therapy.
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